Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL-HIV trial: DATASET

Sculier, Delphine; Wandeler, Gilles; Yerly, Sabine; Marinosci, Annalisa; Stoeckle, Marcel; Bernasconi, Enos; Braun, Dominique L; Vernazza, Pietro; Cavassini, Matthias; Buzzi, Marta; Metzner, Karin J; Decosterd, Laurent; Günthard, Huldrych F; Schmid, Patrick; Limacher, Andreas; Egger, Matthias; Calmy, Alexandra; Swiss HIV, Cohort Study (2020). Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL-HIV trial: DATASET [Dataset]. University of Bern

[img]
Preview
Text
Dataset Information Simpl-HIV 8Oct2020.pdf - Other
Available under License Creative Commons: Attribution (CC-BY).

Download (30kB) | Preview

Item Type:

Dataset

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)
04 Faculty of Medicine > Pre-clinic Human Medicine > CTU Bern
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Wandeler, Gilles; Limacher, Andreas and Egger, Matthias

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

Publisher:

University of Bern

Language:

English

Submitter:

Beatrice Minder Wyssmann

Date Deposited:

02 Oct 2020 16:36

Last Modified:

16 Nov 2020 12:13

Related URLs:

BORIS DOI:

10.7892/boris.146808

URI:

https://boris.unibe.ch/id/eprint/146808

Actions (login required)

Edit item Edit item
Provide Feedback